A96G (p.Ala96Gly) variant of CASQ2 (Calsequestrin-2)

A96G (p.Ala96Gly) in CASQ2 (Calsequestrin-2) is a missense change. Clinical records from ClinVar and UniProt describe it as uncertain significance in the context of Catecholaminergic polymorphic ventricular tachycardia 1. The available variant effect predictions contribute to a CATVariant prioritization score of 0.34 / 1. The record also includes population frequency data and structural context.

A96G (p.Ala96Gly) variant details